Mediastinal staging of non-small-cell lung cancer
نویسندگان
چکیده
منابع مشابه
The non‐invasive mediastinal staging of non‐small lung cancer
Four years after the 1st edition [1], the American College of Chest Physicians (ACCP) has published its 2nd edition of their evidence based clinical practice guidelines on the di‐ agnosis and management of lung cancer [2]. The goal of these guidelines is to assist chest physicians in achieving the best outcomes possible for their patients taking into account the new evidence based knowledge and...
متن کاملStaging of Non-Small-Cell Lung Cancer.
Staging of lung cancer serves 2 purposes; it attempts to classify patients into groups where particular treatments are appropriate and defines those groups based on expected prognosis. The eighth edition of the International Association for the Study of Lung Cancer staging system deals with the issues raised by screening with fine cut computed tomography. Each phase of staging is a legitimate d...
متن کاملStaging non-small cell lung cancer*
Patients with newly diagnosed non-small cell lung cancer (NSCLC) need accurate tumor staging in order to direct appropriate therapy and establish prognosis; the tumor is usually staged using the TNM system. The major imaging modalities currently used for staging this disease are thoracic computed tomography (CT) (including the adrenal glands) and whole body fluorodeoxyglucose (FDG)-positron emi...
متن کاملOptimal sequence of tests for the mediastinal staging of non-small cell lung cancer
BACKGROUND Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer and the most difficult to predict. When there are no distant metastases, the optimal therapy depends mainly on whether there are malignant lymph nodes in the mediastinum. Given the vigorous debate among specialists about which tests should be used, our goal was to determine the optimal sequence of tests for ...
متن کاملRole of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer.
OBJECTIVE Positron emission tomography (PET) is used increasingly in staging of non-small cell lung cancer (NSCLC) as a non-invasive tool. The role of the PET in mediastinal lymphatic staging of NSCLC is not clear. We aimed to demonstrate the efficacy of PET in determining mediastinal lymphatic metastasis by comparing the results of PET with mediastinoscopy. PATIENTS AND METHODS We performed ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Respiratory Medicine
سال: 2011
ISSN: 1747-6348,1747-6356
DOI: 10.1586/ers.11.75